CNS Pharmaceuticals Held Annual Shareholder Meeting
I'm PortAI, I can summarize articles.
CNS Pharmaceuticals Inc. held its Annual Shareholder Meeting on November 17, 2025. Shareholders approved amendments to the 2020 Equity Plan, increasing authorized shares for issuance. The board of directors was elected, and amendments to the Articles of Incorporation were approved, increasing authorized shares of common and preferred stock. This news was generated by Public Technologies using AI and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments